Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

SVP, Chief Sci.&Tech. Officer

SVP, Chief Manuf. Officer

SVP, COO & CFO

SVP, Chief Development Officer

VP, Chief Accounting Officer

SVP, Chief Legal Officer

SVP, Chief Financial Officer

VP, Controller

SVP, CMO

Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet needs. The company develops XMT-1660, a B7-H4-targeted Dolasynthen ADC candidate; and XMT-2056, an immunosynthen ADC. It has a research and development collaborations with Janssen Biotech, Inc. and Merck KGaA, as well as collaboration agreement with Asana BioSciences, LLC for the development of ADC product candidates. The company was formerly known as Nanopharma Corp. and changed its name to Mersana Therapeutics, Inc. in November 2005. Mersana Therapeutics, Inc. was incorporated in 2001 and is headquartered in Cambridge, Massachusetts.

Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with u...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-01-16	Premium	sold	Premium	Premium	Premium	SVP, Chief Sci.&Tech. Officer
2024-01-16	Premium	sold	Premium	Premium	Premium	SVP, Chief Manuf. Officer
2024-01-16	Premium	sold	Premium	Premium	Premium	SVP, COO & CFO
2024-01-16	Premium	sold	Premium	Premium	Premium	SVP, Chief Development Officer
2024-01-16	Premium	sold	Premium	Premium	Premium	VP, Chief Accounting Officer
2024-01-16	Premium	sold	Premium	Premium	Premium	-
2024-01-16	Premium	sold	Premium	Premium	Premium	SVP, Chief Legal Officer
2024-01-15	Premium	acquired	Premium	Premium	Premium	-
2024-01-15	Premium	acquired	Premium	Premium	Premium	SVP, Chief Sci.&Tech. Officer
2024-01-15	Premium	acquired	Premium	Premium	Premium	VP, Chief Accounting Officer
2024-01-15	Premium	acquired	Premium	Premium	Premium	SVP, COO & CFO
2024-01-14	Premium	acquired	Premium	Premium	Premium	-
2024-01-14	Premium	acquired	Premium	Premium	Premium	VP, Chief Accounting Officer
2024-01-14	Premium	acquired	Premium	Premium	Premium	SVP, Chief Manuf. Officer
2024-01-14	Premium	acquired	Premium	Premium	Premium	SVP, Chief Legal Officer
2024-01-14	Premium	acquired	Premium	Premium	Premium	SVP, Chief Sci.&Tech. Officer
2024-01-14	Premium	acquired	Premium	Premium	Premium	SVP, COO & CFO
2024-01-13	Premium	acquired	Premium	Premium	Premium	-
2024-01-13	Premium	acquired	Premium	Premium	Premium	VP, Chief Accounting Officer
2024-01-13	Premium	acquired	Premium	Premium	Premium	SVP, Chief Legal Officer
2024-01-13	Premium	acquired	Premium	Premium	Premium	SVP, Chief Manuf. Officer
2024-01-13	Premium	acquired	Premium	Premium	Premium	SVP, Chief Development Officer
2024-01-13	Premium	acquired	Premium	Premium	Premium	SVP, Chief Sci.&Tech. Officer
2024-01-13	Premium	acquired	Premium	Premium	Premium	SVP, COO & CFO
2024-01-02	Premium	acquired	Premium	Premium	Premium	-

MRSN - Mersana Therapeutics Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for MRSN